Centessa on Track to Unveil ORX750 Clinical Data for Narcolepsy
Centessa Pharmaceuticals spotlighted progress in its orexin agonist program aimed at treating narcolepsy and sleep-wake disorders.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
